Valosin-containing protein gene mutations: Clinical and neuropathologic features

Neurology

Volumn 67, Issue 4, 2006, Pages 644-651

  Guyant Marechal L ^a   Laquerriere A ^a   Duyckaerts, C ^b   Dumanchin, C ^c   Bou, J ^c   Dugny, F ^c   Le Ber, I ^c   Frebourg T ^c   Hannequin, D ^a   Campion, D ^c  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

UBIQUITIN; UNCLASSIFIED DRUG; VALOSIN CONTAINING PROTEIN;

ADULT; AGED; ARTICLE; BONE; BRAIN; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER; MISSENSE MUTATION; MUSCLE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; UBIQUITINATION;

CELL CYCLE PROTEINS; CHROMOSOME DISORDERS; DEMENTIA; DNA MUTATIONAL ANALYSIS; FEMALE; FRANCE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; MUTATION; MYOSITIS, INCLUSION BODY; OSTEITIS DEFORMANS; PEDIGREE; PREVALENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SYNDROME;

EID: 33746926801     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000225184.14578.d3     Document Type: Article

References (30)

1. Kovach MJ, Waggoner B, Leal SM, et al. Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Mol Genet Metab 2001;74:458-475.
2. Watts GD, Wymer J, Kovach MJ, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 2004;36:377-381.
3. Zhang X, Shaw A, Bates PA, et al. Structure of the AAA ATPase p97. Mol Cell 2000;6:1473-1484.
4. Ye Y, Meyer HH, Rapoport TA. The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Nature 2001;414:652-656.
5. Zhong X, Shen Y, Ballar P, Apostolou A, Agami R, Fang S. AAA ATPase p97/valosin-containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum-associated degradation. J Biol Chem 2004;279:45676-45684.
6. Dai RM, Li CC. Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation. Nat Cell Biol 2001;3:740-744.
7. Hirabayashi M, Inoue K, Tanaka K, et al. VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration. Cell Death Differ 2001;8:977-984.
8. Kobayashi T, Tanaka K, Inoue K, Kakizuka A. Functional ATPase activity of p97/valosin-containing protein (VCP) is required for the quality control of endoplasmic reticulum in neuronally differentiated mammalian PC12 cells. J Biol Chem 2002;277:47358-47365.
9. Wojcik C, Yano M, DeMartino GN. RNA interference of valosin-containing protein (VCP/p97) reveals multiple cellular roles linked to ubiquitin/ proteasome-dependent proteolysis. J Cell Sci 2004;117:281-292.
10. Cummings JL. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology 1997;48:S10-6.
11. Kertesz A, Davidson W, Fox H. Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia. Can J Neurol Sci 1997;24:29-36.
12. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
13. Schmidt R, Freidl W, Fazekas F, et al. The Mattis Dementia Rating Scale: normative data from 1,001 healthy volunteers. Neurology 1994;44:964-966.
14. Grober E, Buschke H. Genuine memory deficits in dementia. Dev Neuropsychol 1987;3:13-36.
15. Wechsler D. Echelle Clinique de Mémoire. Forme 1. Paris: Edition du Centre de Psychologie Appliquée; 1970.
16. Rey A. Test de copie et de reproduction de mémoire de figures géométriques complexes. Paris: Edition du Centre de Psychologie Appliquée; 1970.
17. Cardebat D, Doyon B, Puel M, Goulet P, Joanette Y. Formal and semantic lexical evocation in normal subjects. Performance and dynamics of production as a function of sex, age and educational level. Acta Neurol Belg 1990;90:207-217.
18. Deloche G, Hannequin D. DO80. Paris: Edition du Centre de Psychologie Appliquée; 1997.
19. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology 2000;55:1621-1626.
20. Nelson HE. A modified card sorting test sensitive to frontal lobe defects. Cortex 1976;12:313-324.
21. Le Ber I, Martinez M, Campion D, et al. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24. Brain 2004;127:1979-1992.
22. Hope AD, de Silva R, Fischer DF, Hol EM, Van Leuween FW, Lees AJ. Alzheimer's associated variant ubiquitin causes inhibition of the 26S proteasome and chaperone expression. J Neurochem 2003;86:394-404.
23. Dickson DW, Wertkin A, Kress Y, et al. Ubiquitin immunoreactive structures in normal human brains. Lab Invest 1990;63:87-99.
24. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
25. Nan L, Wu Y, Bardag-Gorce F, et al. RNA interference of VCP/p97 increases Mallory body formation. Exp Mol Pathol 2005;78:1-9.
26. Mann DM. Dementia of frontal type and dementias with subcortical gliosis. Brain Pathol 1998;8:325-338.
27. Schröder R, Watts GD, Mehta SG, et al. Mutant valosin-containing protein causes a novel type of frontotemporal dementia. Ann Neurol 2005;57:457-461.
28. Riley NE, Li J, Worrall S, et al. The Mallory body as an aggresome: in vitro studies. Exp Mol Pathol 2002;72:17-23.
29. Meyer HH. Golgi reassembly after mitosis: The AAA family meets the ubiquitin family. Biochim Biophys Acta 2005;1744:108-119.
30. Costantini P, Bruey JM, Castedo M, et al. Pre-processed caspase-9 contained in mitochondria participates in apoptosis. Cell Death Differ 2002;9:82-88.